The Food Safety and Standards Authority of India (FSSAI) issued an order on Wednesday directing the immediate removal of fruit-based beverages, ready-to-serve drinks, energy drinks, electrolyte drinks and similar products that use the term "ORS" in their brand or product names.
The observation was made while hearing a petition filed by Dr. Reddy's Laboratories, which had challenged the FSSAI's notification barring the manufacture and sale of drinks bearing the expression "ORS" (Oral Rehydration Solution) in their brand names or trademarks.
Out of the Nifty 50 companies, 21 stocks advanced while 30 declined. Among the top gainers were Cipla, Adani Ports, ITC Hotels, Dr. Reddy's, and HDFC Life. On the other hand, Trent, BEL, Bharti Airtel, Titan, and ONGC emerged as the biggest losers, dragging the index lower.
The broad market showed a mixed performance, with 37 stocks advancing and 13 declining from the Nifty 50 index.
Among the top gainers were Maruti, M&M, LT, Bajaj Finance, and Tata Motors, which saw strong upward movements, while Hindalco, Dr Reddy's, Adani Ports, ONGC, and Tata Steel st
Mumbai (Maharashtra) [India], September 26: Mission Arthritis India (MAI), in collaboration with Dr. Reddy's Laboratories Ltd., has achieved a significant milestone by setting a new record in the Asia Book of Records for the 'Maximum Healthcare Professionals (HCPs) Recommended Arthritis Pati
Hyderabad (Telangana)/ New Delhi [India], May 14: The Indian Chest Society (ICS) today unveiled a special booklet titled 'Guidelines For Cough Management in India', focusing on the comprehensive management of cough in India. This initiative comes at a crucial time when respiratory health is
Among the Nifty companies, 24 saw advances while 25 faced declines. Grasim, Bharti Airtel, Nestle India, Maruti, and Tata Motors emerged as the top gainers, while Sun Pharma, BPCL, Reliance, Dr Reddy, and Hindalco were among the top losers.
Hyderabad (Telangana) [India], January 9: Woxsen University in Hyderabad was honoured today to host Yves Leterme, Former Prime Minister of Belgium, on its campus. Leterme's visit was a significant highlight of the International Conclave focusing on 'India-EU as Strategic Partners for the Fut
The pharma's revenue went up 16 per cent to Rs 6,297 crore during the quarter reviewed, over the figure in the corresponding period the previous year. Its Ebitda went up 25.9 per cent to Rs. 1,631 crore while its gross margin was at 57.2 per cent in Q4 FY23.
BSE Sensex went down 71 points to 61,689.38 and NSE Nifty lost 21 points to 18,244.35. The top gainers on Nifty 50 were IndusInd Bank, Tata Motors, Power Grid, Bajaj Auto and HCL Tech while the losers were UPL, Dr Reddy, SBIN, Grasim and Adani Ports.
New Delhi [India], March 21 (ANI/BusinessWire India): Integrated Health and Wellbeing Council (IHW Council), in collaboration with Dr Reddy's Laboratories Limited and Apollo Hospitals, organised a unique 'Kidney Health Summit 2023' to address the rising epidemic of chronic kidney diseases in
FY22-23 is the first year of production for the PLI Scheme for pharmaceuticals, the department said, adding that the department has earmarked about Rs 690 crore as Budget outlay in the present fiscal.